Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-28
2006-03-28
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07019010
ABSTRACT:
The present invention relates to a pharmaceutical composition, comprising(a) a phosphodiesterase 5 inhibitor or a pharmaceutically acceptable salt thereof and(b) at least one of the active ingredients selected from the group consisting of(i) an anti-diabetic agent;(ii) HMG-Co-A reductase inhibitors;(iii) an anti-hypertensive agent; and(iv) a serotonin reuptake inhibitor (SSRI)or, in each case, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. The pharmaceutical composition may be employed for the treatment of sexual dysfunction, hyperglycemia, hyperinsulinaemia, hyperlipidaemia, hypertriglyceridemia, diabetes, insulin resistance, impaired glucose metabolism, conditions of impaired glucose tolerance (IGT), conditions of impaired fasting plasma glucose, obesity, diabetic retinopathy, diabetic nephropathy, glomerulosclerosis, diabetic neuropathy, syndrome X, erectile dysfunction, coronary heart disease, hypertension, especially ISH, angina pectoris, myocardial infarction, stroke, vascular restenosis, endothelial dysfunction, impaired vascular compliance, congestive heart failure.
REFERENCES:
patent: 5260332 (1993-11-01), Dufresne
patent: 2003/0171384 (2003-09-01), Bhalay et al.
patent: WO 00/37061 (2000-06-01), None
patent: WO 2001/19357 (2001-03-01), None
patent: WO 02/13798 (2002-02-01), None
patent: WO 03/099194 (2003-04-01), None
patent: WO 2004002461 (2004-01-01), None
Khan et al.‘Endothelin and erectile dysfunction: a target for pharmaceutical intervention,’ Exp. Opin. Invest. Drugs, 1998, vol. 7 No. 11, pp. 1759-1767.
Ferraro Gregory D.
Novertis AG
Wang Shengjun
Zhang Cynthia
LandOfFree
Combinations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3605504